Horizoe; Tatsuo
Patent Applications and Registrations
Patent applications and USPTO patent grants for Horizoe; Tatsuo.The latest application filed is for "neutralizing anti-ccl20 antibodies".
- Horizoe; Tatsuo - Moriya JP
- Horizoe; Tatsuo - Moriya-shi JP
- Horizoe; Tatsuo - Ibaraki JP
- Horizoe; Tatsuo - Tsukuba JP
- Horizoe; Tatsuo - Tsukuba-shi JP
- Horizoe; Tatsuo - Ushiku JP
| Patent | Date |
|---|---|
| Neutralizing anti-CCL20 antibodies Grant 9,809,647 - Imai , et al. November 7, 2 | 2017-11-07 |
| Neutralizing Anti-ccl20 Antibodies App 20160046707 - Imai; Toshio ; et al. | 2016-02-18 |
| Nucleic acids encoding neutralizing anti-CCL20 antibodies Grant 9,133,273 - Imai , et al. September 15, 2 | 2015-09-15 |
| Neutralizing Anti-ccl20 Antibodies App 20140045215 - Imai; Toshio ; et al. | 2014-02-13 |
| Neutralizing anti-CCL20 antibodies Grant 8,491,901 - Imai , et al. July 23, 2 | 2013-07-23 |
| Neutralizing Anti-ccl20 Antibodies App 20120148592 - Imai; Toshio ; et al. | 2012-06-14 |
| Triazolone derivatives Grant 8,163,787 - Clark , et al. April 24, 2 | 2012-04-24 |
| Triazolone Derivatives App 20110112109 - CLARK; Richard ; et al. | 2011-05-12 |
| Triazolone derivatives Grant 7,928,228 - Clark , et al. April 19, 2 | 2011-04-19 |
| Triazolone derivatives Grant 7,816,522 - Clark , et al. October 19, 2 | 2010-10-19 |
| Hydrazide Derivatives App 20100240654 - CLARK; Richard ; et al. | 2010-09-23 |
| Triazolone Derivatives App 20100190783 - CLARK; Richard ; et al. | 2010-07-29 |
| Hydrazide Derivatives App 20080132507 - Clark; Richard ; et al. | 2008-06-05 |
| Triazolone derivatives App 20080015199 - Clark; Richard ; et al. | 2008-01-17 |
| Concomitant drug as therapeutic agent for inflammatory bowel disease App 20060177444 - Horizoe; Tatsuo | 2006-08-10 |
| Purine derivatives and adenosine A2 receptor antagonists serving as preventives/remedies for diabetes Grant RE39,112 - Asano , et al. May 30, 2 | 2006-05-30 |
| Condensed imidazole compounds and a therapeutic agent for diabetes mellitus Grant 6,841,549 - Asano , et al. January 11, 2 | 2005-01-11 |
| Purine derivatives and adenosine A2 receptor antagonists serving as preventives/remedies for diabetes Grant 6,579,868 - Asano , et al. June 17, 2 | 2003-06-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 